XBI icon

SPDR S&P Biotech ETF

274 hedge funds and large institutions have $2.17B invested in SPDR S&P Biotech ETF in 2016 Q4 according to their latest regulatory filings, with 83 funds opening new positions, 75 increasing their positions, 72 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding in top 10

Funds holding in top 10:

28% less call options, than puts

Call options by funds: $793M | Put options by funds: $1.1B

29.78% less ownership

Funds ownership: 118.69%88.91% (-30%)

30% less capital invested

Capital invested by funds: $3.11B → $2.17B (-$946M)

Holders
274
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
6
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$793M
Puts
$1.1B
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
201
$251K
202
$250K
203
$249K
204
$247K
205
$242K
206
$236K
207
$235K
208
$233K
209
$227K
210
$226K
211
$222K
212
$217K
213
$216K
214
$214K
215
$213K
216
$209K
217
$206K
218
$202K
219
$201K
220
$200K
221
$198K
222
$140K
223
$125K
224
$116K
225
$114K